Intrexon | L'Utile Ante Imposte





L'Utile Ante Imposte Cambiamento Data
Agenus USD -274.14M 80.46M 2025-09
Alaunos Therapeutics USD -7.84M 633K 2023-12
Amgen USD 3.92B 2.35B 2025-09
Anika Therapeutics USD -3.87M 32.43M 2025-03
Arrowhead Research USD 28.27M 7.85M 2025-12
AstraZeneca USD 3.24B 117M 2025-09
Bristol-Myers Squibb USD 3.11B 1.34B 2025-09
Gilead Sciences USD 3.64B 1.21B 2025-09
GlaxoSmithKline GBP 1.23B 1.23B 2025-12
Heron Therapeutics USD -4.85M 4.39M 2024-09
Incyte USD 482.31M 75.7M 2025-09
Intrexon USD -60.48M 27.09M 2024-06
Karyopharm Therapeutics USD -30.89M 1.16M 2024-12
Ligand Pharmaceuticals USD 141.14M 102M 2025-09
MacroGenics USD 16.82M 52.97M 2025-09
MannKind USD 7.78M 6.84M 2025-09
Merck USD 6.74B 22M 2025-09
Novartis USD 4.2B 335M 2025-09
Rigel Pharmaceuticals USD -1.03M 7.22M 2024-06
Roche Holding CHF 4.79B 3.01B 2025-06
Sangamo BioSciences USD -36.05M 12.94M 2024-06
Thermo Fisher Scientific USD 2.12B 295M 2025-12
Veracyte USD 18.89M 17.64M 2025-09
Xencor USD -6.03M 25.05M 2025-09


Intrexon L'Utile Ante Imposte - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.